See also this year's filing and all EDGAR filings for this company.
PDF Report 0001517681_2021_Propanc_Biopharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001517681')"} |
Graph
Absolute values for 0001517681, Propanc Biopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 69,022 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,747 |
| 3 | remainder_Assets | 23,749 |
| 4 | LiabilitiesCurrent | 3,739,943 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,281,464 |
| 9 | ResearchAndDevelopmentExpense | 179,987 |
| 10 | remainder_Expenses | -101,919 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,381,191 |
| 13 | remainder_ComprehensiveNetIncome | 200,673 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 98,518 |
| 1 | Liabilities | 3,739,943 |
| 2 | Expenses | 3,359,532 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -3,641,425 |
| 5 | NetIncome | -4,740,723 |
| 6 | ComprehensiveNetIncome | -4,640,386 |
| 7 | BaseVar | 4,389,928 |
| 8 | EconomicCapitalRatio | -5.68 |